# Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/gefitinib-versus-vinorelbine-plus-cisplatin-as-adjuvant-treatment-for-stage-ii/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Wen‐Zhao Zhong,Qun Wang,Weimin Mao,Lin Xu,Lin Wu,Yi Shen,Yu Liu,Chun Chen,Ying Cheng,Lin Xu,Jun Wang,Fei Ke,Xiaofei Li,Jian Li,Cheng Huang,Zhidong Liu,Shun Xu,Ke‐Neng Chen,Shidong Xu,Lunxu Liu,Ping Yu,Buhai Wang,Haitao Ma,Hong‐Hong Yan,Xue‐Ning Yang,Qing Zhou,Yi‐Long Wu,Yi‐Long Wu,Qun Wang,Weimin Mao,Lin Wu,Yi Shen,Yu Liu,Chun Chen,Ying Cheng,Lin Xu,Jun Wang,Fei Ke,Xiaofei Li,Jian Li,Cheng Zhi Huang,Zhidong Liu,Shun Xu,Ke‐Neng Chen,Shidong Xu,Lunxu Liu,Ping Yu,Buhai Wang,Haitao Ma,Siyu Wang,Jian Hu,Wei Liu,Wěi Li,Jianhua Shi |
| Citations | 530 |
| DOI | 10.1016/s1470-2045(17)30729-5 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2768989095 |
| PMID | 29174310 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Wen‐Zhao Zhong](https://scholariq.org/researchers/wen-zhao-zhong/)
- [Hong‐Hong Yan](https://scholariq.org/researchers/hong-hong-yan/)
- [Ying Cheng](https://scholariq.org/researchers/ying-cheng/)
- [Lin Wu](https://scholariq.org/researchers/lin-wu/)
- [Qing Zhou](https://scholariq.org/researchers/qing-zhou/)
- [Yi‐Long Wu](https://scholariq.org/researchers/yi-long-wu/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.